Clinical investigation of receptor and non-receptor tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer

By Klempner Samuel J   Myers Andrea P   Mills Gordon B   Westin Shannon N  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2171-2182

Informa Healthcare

Access to resources Recommend Favorite

A QSAR Study on a Series of Indolin-2-Ones Acting as Non-Receptor Src Tyrosine Kinase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 10, 2011-12 ,pp. : 918-925

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells

By  

Current Medicinal Chemistry, Vol. 23, Iss. 15, 2016-05 ,pp. : 1496-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Predictive Biomarkers to Tyrosine Kinase Inhibitors for the Epidermal Growth Factor Receptor in Non-Small-Cell Lung Cancer

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 851-864

Bentham Science Publishers

Access to resources Recommend Favorite

Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer

By Nakata Asuka   Gotoh Noriko  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 8, 2012-08 ,pp. : 771-781

Informa Healthcare

Access to resources Recommend Favorite